The company maintains a debt-to-equity ratio of 0.71 as of 2026Q1, reflecting a reliance on external financing to manage $9.6 billion in goodwill and ongoing operational liabilities.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 9.79B | 9.93B | 10.02B | 9.94B | 10.26B | 10.35B | 11.23B | 9.46B | 9.57B | 10.12B | 14.07B | 12.69B | 12.41B | 11.47B | 12.53B | 12.48B | 14.6B | 11.91B | 12.03B | 17.86B | 14.96B | 15.09B | 13.31B | 11.48B | 11.06B | 11.48B | 13.32B | 14.92B | 16.18B | 14.21B | 14.93B |
| Cash & Short-Term Investments | 2.59B | 2.79B | 2.4B | 1.87B | 1.18B | 2.31B | 3.23B | 1.43B | 2.12B | 1.94B | 2.44B | 1.78B | 2B | 2.48B | 3.83B | 3.15B | 5.83B | 4.39B | 3.62B | 8.78B | 6.02B | 5.29B | 4.35B | 3.07B | 1.86B | 1.02B | 1.2B | 3.86B | 6.52B | 1.69B | 989.07M |
| Cash Only | 2.59B | 2.79B | 2.4B | 1.87B | 1.17B | 2.3B | 3.23B | 1.43B | 1.69B | 1.94B | 2.33B | 1.77B | 1.87B | 2.46B | 3.83B | 3.15B | 5.83B | 4.39B | 3.62B | 8.78B | 6.02B | 5.29B | 4.35B | 3.07B | 1.86B | 891.26M | 1.09B | 2.34B | 6.52B | 1.69B | 989.07M |
| Short-Term Investments | 0 | 0 | 2M | 3M | 11M | 2M | 0 | 1M | 436M | 2M | 101M | 12M | 125M | 10M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 130.37M | 111.8M | 1.53B | 0 | 0 | 0 |
| Accounts Receivable | 3.31B | 3.53B | 3.67B | 4.25B | 4.65B | 4.29B | 4.16B | 5.02B | 4.18B | 4.2B | 5.63B | 5.1B | 4.86B | 4.75B | 4.68B | 4.99B | 4.43B | 3.98B | 4.29B | 4.68B | 4.73B | 4.63B | 4.52B | 4.62B | 5.07B | 5.82B | 6.52B | 6.1B | 5.11B | 5.2B | 6.28B |
| Days Sales Outstanding | 69.51 | 72.25 | 74.37 | 85.4 | 95.27 | 91.23 | 87.64 | 106.84 | 84.24 | 86.3 | 83.81 | 76.72 | 82.98 | 74.29 | 68.94 | 80.67 | 63.67 | 62.69 | 59.33 | 63.61 | 64.02 | 55.7 | 54.51 | 58.18 | 58.13 | 65.59 | 62.67 | 70.56 | 61.57 | 55.36 | 71.86 |
| Inventory | 3.11B | 2.87B | 3.2B | 3.49B | 4.05B | 3.45B | 2.99B | 2.77B | 2.67B | 2.35B | 3.39B | 3.46B | 3.31B | 3.24B | 3.5B | 3.63B | 3.87B | 2.91B | 3.37B | 3.21B | 2.88B | 3.48B | 3.23B | 3.2B | 3.53B | 4.3B | 5.29B | 4.58B | 4.25B | 5.12B | 4.97B |
| Days Inventory Outstanding | 117.32 | 107.16 | 113.9 | 118.85 | 138.99 | 126.08 | 116.21 | 110.03 | 102.01 | 89.46 | 89.04 | 87.85 | 91.74 | 86.69 | 82.95 | 94.97 | 88.88 | 70.37 | 68.67 | 66.33 | 56.27 | 61.74 | 58.49 | 59.79 | 58.68 | 68.64 | 67.16 | 68.02 | 64.68 | 72.42 | 73.64 |
| Other Current Assets | 775.81M | 738M | 511M | 129M | 200M | 132M | 682M | 53M | 776M | 1.71B | 2.66B | 2.49B | 2.3B | 946M | 852M | 1.13B | 465M | 627M | 749M | 1.19B | 1.18B | 2.09B | 1.22B | 0 | 952.97K | 0 | -1.06M | 993.79K | -64.8M | 2.64B | 1.86B |
| Total Non-Current Assets | 17.5B | 17.01B | 18.95B | 19.47B | 20.43B | 20.61B | 16.49B | 17.56B | 16.45B | 15.2B | 18.23B | 18.28B | 15.95B | 15.09B | 16.55B | 16.49B | 17.67B | 18.62B | 19.76B | 18.54B | 23.53B | 18.74B | 17.39B | 17.47B | 21.26B | 27.04B | 25.33B | 14.67B | 11.82B | 12.46B | 10.47B |
| Property, Plant & Equipment | 2.18B | 2.22B | 2.45B | 2.48B | 2.64B | 2.7B | 2.68B | 2.87B | 1.71B | 1.59B | 2.15B | 2.32B | 2.1B | 2.78B | 2.96B | 3.01B | 3.27B | 3.25B | 3.5B | 3.19B | 3.1B | 4.89B | 4.99B | 4.87B | 6.14B | 7.73B | 9.07B | 7.35B | 6.54B | 7.23B | 7.2B |
| Fixed Asset Turnover | 7.98x | 8.04x | 7.35x | 7.31x | 6.76x | 6.36x | 6.46x | 5.98x | 10.58x | 11.18x | 11.38x | 10.44x | 10.21x | 8.39x | 8.38x | 7.49x | 7.79x | 7.13x | 7.55x | 8.43x | 8.70x | 6.21x | 6.07x | 5.95x | 5.19x | 4.19x | 4.19x | 4.29x | 4.63x | 4.75x | 4.43x |
| Goodwill | 9.62B | 9.27B | 10.38B | 9.88B | 10.24B | 10.64B | 8.01B | 8.65B | 8.5B | 7.73B | 8.9B | 8.52B | 7.16B | 6.5B | 6.95B | 7.02B | 8.04B | 7.36B | 7.28B | 4.14B | 3.82B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 2.69B | 2.57B | 2.98B | 3.19B | 3.53B | 3.65B | 3B | 3.47B | 3.59B | 3.32B | 3.55B | 3.69B | 3.37B | 3.26B | 3.73B | 4B | 4.2B | 4.16B | 4.48B | 2.16B | 1.91B | 4.04B | 2.8B | 3.76B | 4.94B | 7.28B | 4.44B | 2.83B | 550.82M | 1.6B | 1.46B |
| Long-Term Investments | 3.37B | 852M | 889M | 1B | 1.2B | 1.06B | 670M | 481M | 604M | 729M | 525M | 670M | 619M | 657M | 726M | 203M | 181M | 281M | 293M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 121.13M | 2.1B | 332M | 287M | 381M | 355M | 303M | 225M | 211M | 227M | 306M | 317M | 246M | 207M | 270M | 544M | 642M | 2.32B | 3.28B | 9.06B | 13.56B | 9.81B | 9.59B | 8.84B | 10.18B | 12.02B | 11.82B | 4.48B | 4.73B | 3.64B | 1.81B |
| Total Assets | 27.29B | 26.94B | 28.98B | 29.41B | 30.69B | 30.96B | 27.71B | 27.02B | 26.02B | 25.32B | 32.3B | 30.98B | 28.35B | 26.56B | 29.08B | 28.97B | 32.27B | 30.53B | 31.79B | 36.4B | 38.5B | 33.83B | 30.7B | 28.95B | 32.32B | 38.52B | 38.65B | 29.58B | 27.99B | 26.67B | 25.4B |
| Asset Turnover | 0.66x | 0.66x | 0.62x | 0.62x | 0.58x | 0.55x | 0.62x | 0.63x | 0.70x | 0.70x | 0.76x | 0.78x | 0.75x | 0.88x | 0.85x | 0.78x | 0.79x | 0.76x | 0.83x | 0.74x | 0.70x | 0.90x | 0.99x | 1.00x | 0.99x | 0.84x | 0.98x | 1.07x | 1.08x | 1.29x | 1.26x |
| Asset Growth % | -17.04% | -7.01% | -1.46% | -4.18% | -0.88% | 11.72% | 2.58% | 3.83% | 2.78% | -21.63% | 4.28% | 9.26% | 6.75% | -8.67% | 0.39% | -10.24% | 5.71% | -3.97% | -12.66% | -5.45% | 13.78% | 10.21% | 6.05% | -10.42% | -16.1% | -0.33% | 30.65% | 5.67% | 4.96% | 5% | 0.19% |
| Total Current Liabilities | 7.44B | 7.51B | 8.14B | 8.29B | 7.93B | 7.45B | 7.74B | 6.98B | 7.94B | 6.87B | 10.47B | 10.07B | 9.23B | 8.48B | 9.96B | 9.34B | 10.76B | 8.05B | 8.91B | 9.65B | 9.13B | 10.37B | 9.17B | 9.23B | 9.13B | 10.94B | 11.56B | 9.63B | 8.86B | 10.76B | 10.41B |
| Accounts Payable | 1.99B | 1.93B | 1.83B | 1.92B | 1.97B | 1.87B | 2.12B | 2.09B | 2.3B | 2.09B | 2.85B | 2.67B | 2.5B | 2.46B | 2.83B | 3.34B | 3.69B | 2.87B | 112M | 3.09B | 3.17B | 3.45B | 3.5B | 3.2B | 3.23B | 3.25B | 4.27B | 3.64B | 2.95B | 2.87B | 2.75B |
| Days Payables Outstanding | 69.44 | 71.95 | 65.18 | 65.26 | 67.56 | 68.41 | 82.27 | 82.89 | 87.85 | 79.46 | 74.76 | 67.81 | 69.18 | 65.88 | 67.28 | 87.5 | 84.87 | 69.33 | 2.28 | 63.85 | 61.97 | 61.32 | 63.37 | 59.81 | 53.78 | 51.88 | 54.12 | 54.1 | 44.91 | 40.58 | 40.75 |
| Short-Term Debt | 1.21B | 1.15B | 224M | 123M | 95M | 53M | 962M | 110M | 1.3B | 585M | 1.58B | 1.67B | 392M | 592M | 809M | 582M | 1.84B | 627M | 722M | 2.35B | 863.01M | 1.17B | 960.46M | 1.68B | 617.52M | 1.27B | 1.75B | 578.39M | 796.38M | 974.54M | 2.56B |
| Deferred Revenue (Current) | 4.72B | 0 | 1.7B | 1.81B | 1.7B | 1.49B | 1.24B | 1.17B | 878M | 372M | 451M | 375M | 312M | 240M | 308M | 3.98B | 3.91B | 3.85B | 4.68B | 2.99B | 3.34B | 3.63B | 3.3B | 2.75B | 3.32B | 4.14B | 3.71B | 3.56B | 2.89B | 4.17B | 0 |
| Other Current Liabilities | 2.42B | 2.81B | 2.19B | 1.93B | 1.95B | 1.39B | 785M | 937M | 2.09B | 1.96B | 3.09B | 3.07B | 3.67B | 2.55B | 2.76B | 1.76B | 1.94B | 1.7B | 4.45B | 1.22B | 1.8B | 2.47B | 1.41B | 1.6B | 1.97B | 2.27B | 1.84B | 1.56B | 2.2B | 4.19B | 1.56B |
| Current Ratio | 1.32x | 1.32x | 1.23x | 1.20x | 1.29x | 1.39x | 1.45x | 1.36x | 1.21x | 1.47x | 1.34x | 1.26x | 1.34x | 1.35x | 1.26x | 1.34x | 1.36x | 1.48x | 1.35x | 1.85x | 1.64x | 1.46x | 1.45x | 1.24x | 1.21x | 1.05x | 1.15x | 1.55x | 1.83x | 1.32x | 1.43x |
| Quick Ratio | 0.90x | 0.94x | 0.84x | 0.78x | 0.78x | 0.93x | 1.06x | 0.96x | 0.87x | 1.13x | 1.02x | 0.92x | 0.99x | 0.97x | 0.91x | 0.95x | 1.00x | 1.12x | 0.97x | 1.52x | 1.32x | 1.12x | 1.10x | 0.90x | 0.83x | 0.66x | 0.69x | 1.07x | 1.35x | 0.84x | 0.96x |
| Cash Conversion Cycle | 117.39 | 107.45 | 123.1 | 138.99 | 166.7 | 148.89 | 121.57 | 133.98 | 98.39 | 96.3 | 98.09 | 96.76 | 105.54 | 95.1 | 84.61 | 88.13 | 67.67 | 63.73 | 125.72 | 66.1 | 58.32 | 56.12 | 49.63 | 58.17 | 63.04 | 82.36 | 75.7 | 84.48 | 81.35 | 87.2 | 104.76 |
| Total Non-Current Liabilities | 8.43B | 8.45B | 8.79B | 9.06B | 9.47B | 9.04B | 8.08B | 7.41B | 5.96B | 6.43B | 8.32B | 9.13B | 8.16B | 6.86B | 7.95B | 7.23B | 6.42B | 7.83B | 7.28B | 4.99B | 6.24B | 6.48B | 6.4B | 6.81B | 9.07B | 8.89B | 4.82B | 4.81B | 4.78B | 6.1B | 7.86B |
| Long-Term Debt | 6.9B | 6.93B | 6.19B | 6.09B | 6.17B | 4.77B | 4.76B | 3.77B | 3.19B | 3.85B | 3.83B | 3.95B | 3.57B | 3.16B | 3.55B | 3.28B | 2.82B | 3.64B | 3.47B | 1.21B | 3.01B | 3.32B | 3.55B | 4.18B | 6.5B | 6.61B | 2.29B | 2.74B | 2.77B | 3.29B | 3.59B |
| Capital Lease Obligations | 0 | 0 | 854M | 864M | 852M | 963M | 948M | 1.11B | 236M | 195M | 194M | 145M | 141M | 145M | 178M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 244.09M | 0 | 81M | 71M | 91M | 83M | 59M | 143M | 152M | 33M | 66M | 164M | 107M | 76M | 92M | 77M | 171M | 530M | 584M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 998.04M | 1.51B | 1.23B | 1.56B | 1.85B | 2.77B | 1.91B | 2.05B | 2.53B | 2.1B | 4.3B | 5.03B | 4.45B | 3.55B | 2B | 2B | 1.71B | 1.93B | 1.44B | 3.78B | 3.23B | 3.17B | 2.85B | 2.62B | 2.57B | 2.29B | 2.53B | 2.07B | 2.01B | 2.82B | 4.26B |
| Total Liabilities | 15.86B | 15.96B | 16.93B | 17.34B | 17.41B | 16.49B | 15.81B | 14.39B | 13.9B | 13.29B | 18.8B | 19.2B | 17.38B | 15.33B | 17.91B | 16.58B | 17.18B | 15.88B | 16.2B | 14.64B | 15.37B | 16.85B | 15.57B | 16.03B | 18.21B | 19.83B | 16.38B | 14.45B | 13.63B | 16.86B | 18.27B |
| Total Debt | 8.11B | 8.09B | 7.49B | 7.29B | 7.34B | 6.05B | 6.93B | 5.26B | 4.82B | 4.72B | 5.61B | 5.76B | 4.1B | 3.9B | 4.53B | 3.86B | 4.66B | 4.27B | 4.19B | 3.56B | 3.87B | 4.48B | 4.51B | 5.87B | 7.12B | 7.88B | 4.04B | 3.32B | 3.57B | 4.26B | 6.16B |
| Net Debt | 5.51B | 5.29B | 5.09B | 5.42B | 6.17B | 3.74B | 3.71B | 3.83B | 3.13B | 2.78B | 3.27B | 3.99B | 2.23B | 1.44B | 700M | 713M | -1.18B | -119M | 568M | -5.22B | -2.15B | -805.47M | 164.5M | 2.8B | 5.26B | 6.99B | 2.95B | 985.84M | -2.95B | 2.57B | 5.17B |
| Debt / Equity | 0.71x | 0.74x | 0.62x | 0.60x | 0.55x | 0.42x | 0.58x | 0.42x | 0.40x | 0.39x | 0.42x | 0.49x | 0.37x | 0.35x | 0.41x | 0.31x | 0.31x | 0.29x | 0.27x | 0.16x | 0.17x | 0.26x | 0.30x | 0.45x | 0.50x | 0.42x | 0.18x | 0.22x | 0.25x | 0.43x | 0.86x |
| Debt / EBITDA | 3.12x | 3.17x | 3.91x | 6.36x | 100.58x | 3.22x | 2.97x | 2.32x | 1.72x | 1.86x | 1.78x | 2.53x | 2.45x | 1.17x | 1.84x | 3.25x | 1.34x | 2.05x | 3.37x | 1.32x | 1.92x | 1.37x | 1.16x | 2.35x | 2.73x | 5.52x | 0.61x | 0.92x | 1.39x | 1.09x | 2.47x |
| Net Debt / EBITDA | 2.12x | 2.08x | 2.65x | 4.73x | 84.52x | 2.00x | 1.59x | 1.69x | 1.12x | 1.09x | 1.04x | 1.76x | 1.33x | 0.43x | 0.28x | 0.60x | -0.34x | -0.06x | 0.46x | -1.93x | -1.07x | -0.25x | 0.04x | 1.12x | 2.02x | 4.89x | 0.45x | 0.27x | -1.15x | 0.66x | 2.07x |
| Interest Coverage | 4.38x | 4.56x | 1.36x | -0.72x | -6.09x | 4.10x | 8.69x | 8.22x | 6.46x | 6.16x | 2.42x | 1.67x | 1.45x | 4.81x | 1.98x | -1.04x | 6.81x | 2.15x | 6.70x | - | - | - | - | 2.04x | 0.15x | 0.02x | - | - | - | - | 0.44x |
| Total Equity | 11.43B | 10.99B | 12.04B | 12.06B | 13.28B | 14.47B | 11.9B | 12.63B | 12.12B | 12.02B | 13.51B | 11.78B | 10.97B | 11.23B | 11.17B | 12.39B | 15.09B | 14.64B | 15.64B | 21.76B | 23.13B | 16.98B | 15.13B | 12.92B | 14.11B | 18.69B | 22.27B | 15.13B | 14.36B | 9.81B | 7.14B |
| Equity Growth % | -35.18% | -8.75% | -0.15% | -9.2% | -8.23% | 21.63% | -5.73% | 4.19% | 0.78% | -10.99% | 14.67% | 7.4% | -2.31% | 0.47% | -9.81% | -17.91% | 3.06% | -6.36% | -28.13% | -5.91% | 36.17% | 12.25% | 17.15% | -8.47% | -24.49% | -16.08% | 47.13% | 5.39% | 46.41% | 37.44% | 4.62% |
| Book Value per Share | 11.80 | 11.42 | 12.90 | 12.71 | 13.95 | 15.23 | 12.43 | 12.98 | 12.15 | 11.94 | 13.65 | 11.97 | 11.15 | 11.42 | 11.31 | 12.14 | 14.94 | 14.79 | 14.72 | 18.60 | 18.35 | 12.71 | 11.06 | 9.49 | 10.38 | 13.72 | 15.70 | 11.05 | 10.49 | 7.16 | 5.10 |
| Total Shareholders' Equity | 11.4B | 10.96B | 12.01B | 12.03B | 13.25B | 14.44B | 11.87B | 12.6B | 12.09B | 12B | 12.6B | 11.66B | 10.87B | 11.21B | 11.14B | 12.36B | 15.05B | 14.6B | 15.59B | 21.72B | 23B | 16.65B | 14.85B | 12.74B | 13.93B | 18.48B | 21.8B | 14.8B | 14.12B | 8.73B | 6.44B |
| Common Stock | 193.2M | 193M | 188M | 183M | 178M | 177M | 182M | 179M | 185M | 188M | 186M | 186M | 187M | 188M | 191M | 202M | 197M | 194M | 194M | 228.39M | 228.06M | 262.58M | 262.61M | 262.82M | 263.02M | 262.99M | 264.06M | 339.88M | 1.66B | 1.64B | 1.63B |
| Retained Earnings | 3.72B | 3.58B | 3.65B | 5.4B | 6.83B | 9.34B | 7.83B | 8.3B | 8.27B | 8.6B | 8.23B | 8.04B | 8.79B | 10.41B | 10.71B | 12.92B | 15.42B | 15.95B | 18.44B | 25.6B | 22.09B | 21.69B | 19.33B | 16.94B | 16.75B | 19.51B | 9.63B | 1.8B | 10.64B | 5.32B | 3.13B |
| Treasury Stock | -265.28M | -298M | -411M | -262M | -275M | -476M | -199M | -201M | -399M | -481M | -181M | -363M | -547M | -718M | -1.1B | -1.69B | -1.08B | -1.19B | -1.29B | -2.22B | -922.87M | -2.92B | -1.24B | -1.25B | -1.31B | -1.3B | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 538.56M | 274M | 1.93B | 879M | 1.49B | 748M | -340M | 652M | 11.9B | 11.81B | 1.28B | 1.13B | 256M | -467M | 35M | 52M | 0 | 0 | -3.24B | -1.89B | 1.61B | -2.47B | -3.6B | -3.28B | -1.79B | 0 | 11.9B | 11.02B | 0 | 0 | 0 |
| Minority Interest | 26.03M | 32M | 37M | 33M | 34M | 36M | 31M | 28M | 29M | 24M | 907M | 118M | 101M | 13M | 34M | 34M | 46M | 49M | 46M | 41.84M | 131.08M | 331.81M | 282.53M | 174.69M | 179.16M | 202.3M | 470.62M | 333.91M | 240.45M | 1.08B | 699.02M |
Litigation and regulatory overhang
According to recent financial disclosures, the company's total assets have contracted from $29.4 billion in 2023Q4 to $27.3 billion in 2026Q1, reflecting a persistent trend of balance sheet shrinkage that complicates the firm's ability to support long-term growth initiatives amidst ongoing operational and legal restructuring efforts.
The reduction in total asset value suggests that the company is struggling to replace its divested business units with high-quality, revenue-generating assets. Investors should monitor whether this contraction is a deliberate optimization of the capital base or a symptom of a shrinking competitive footprint in the medical device market.
Based on reported figures, the debt-to-equity ratio has fluctuated between 0.60 and 0.81 over the last ten quarters, indicating that management is maintaining a significant reliance on external financing to navigate the substantial cash outflows associated with product recalls and ongoing litigation settlements.
While the current leverage levels are not immediately catastrophic, the lack of a clear downward trend in debt suggests that the company's cash flow generation is insufficient to deleverage organically. This reliance on debt in a high-interest rate environment may continue to constrain the firm's financial flexibility and limit its capacity for strategic R&D investment.
As reported in recent filings, the current ratio has hovered near 1.32 as of 2026Q1, providing a modest buffer against short-term obligations, though the volatility in cash balances—which dropped to $1.2 billion in 2025Q1—suggests that the company's liquidity position remains highly sensitive to operational shocks.
The current ratio appears sufficient for day-to-day operations, but it offers little room for error given the unpredictable nature of legal liabilities and potential regulatory fines. The firm's liquidity profile warrants close observation, as any further erosion in cash reserves could force management to seek more expensive or dilutive financing options.
Based on the provided balance sheet data, goodwill remains a significant component of total assets at $9.6 billion in 2026Q1, representing a substantial portion of equity that may be subject to future impairment charges if the company fails to achieve its projected turnaround in core segments.
The high concentration of goodwill relative to total equity suggests that the company's book value may be overstated if the underlying business units do not meet performance expectations. Investors should be wary of the potential for non-cash write-downs, which could further erode the equity base and negatively impact the firm's reported financial health.
Quick answers to the most common questions about buying PHG stock.
As of 2025, Koninklijke Philips N.V. (PHG) had total assets of $26.94B including $9.93B in current assets.
Koninklijke Philips N.V. (PHG) carries total debt of $8.09B, offset by $2.79B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Koninklijke Philips N.V. (PHG) has total shareholders' equity (book value) of $10.96B ($11.42 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Koninklijke Philips N.V. (PHG) reported a current ratio of 1.32x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.